Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
OSIRIS THERAPEUTICS (OSIR)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: OSIR
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
Top Authors
Most frequent coverage on OSIR
Mike Havrilla
(1926 followers)
Stem Cell Index Surges in Past Week
(Mon, May 11)
FDA, Clinical Trial Calendar Updates: Genzyme, Isis, Osiris, Roche, Watson
(Thu, Apr 23)
Banking on NeoStem
(Sun, Apr 12)
More by Mike Havrilla on OSIR »
Justin M. Hall
(672 followers)
Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers
(Sun, Sep 20)
Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up
(Fri, Sep 11)
'Lucky 13 Portfolio': Fuel Systems and Three Cancer Drug Makers
(Tue, Aug 25)
More by Justin M. Hall on OSIR »
TickerSense
(134 followers)
Russell 3000's Best and Worst Stocks, Week and Year to Date
(Sat, Mar 24)
Russell 3000's Best and Worst Stocks, Week and Year to Date
(Sun, Mar 11)
Russell 3000's Best Performing Stocks of 2006
(Tue, Dec 26)
More by TickerSense on OSIR »
Most followed authors on OSIR
Mike Havrilla
(1926 followers)
Stem Cell Index Surges in Past Week
(Mon, May 11)
FDA, Clinical Trial Calendar Updates: Genzyme, Isis, Osiris, Roche, Watson
(Thu, Apr 23)
Banking on NeoStem
(Sun, Apr 12)
More by Mike Havrilla on OSIR »
Richard Shaw
(1068 followers)
Little Rays of Sunshine in the Markets
(Fri, Feb 6)
More by Richard Shaw on OSIR »
Zacks.com
(1057 followers)
Optimistic on Osiris Therapeutics
(Fri, May 8)
Osiris Hits a Speedbump in Crohn's Program
(Fri, Mar 27)
Know Your Options When Investing in Biotech Stocks
(Mon, Mar 2)
More by Zacks.com on OSIR »
Newest authors on OSIR
Justin M. Hall
(672 followers)
Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers
(Sun, Sep 20)
Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up
(Fri, Sep 11)
'Lucky 13 Portfolio': Fuel Systems and Three Cancer Drug Makers
(Tue, Aug 25)
More by Justin M. Hall on OSIR »
M. E. Garza
(520 followers)
Cryo-Cell: The Stem Cell Sector's Profit Leader, Part 2
(Thu, Aug 27)
Cryo-Cell: The Stem Cell Sector's Profit Leader, Part 1
(Thu, Aug 27)
Adult Stem Cell Drugs and Therapies Are the Next Big Market
(Thu, Jun 18)
More by M. E. Garza on OSIR »
optionMONSTER
(657 followers)
Expiration Trade Behind Osiris Activity
(Fri, Nov 20)
More by optionMONSTER on OSIR »
Most commented on OSIR
Justin M. Hall
(672 followers)
Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers
(Sun, Sep 20)
Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up
(Fri, Sep 11)
'Lucky 13 Portfolio': Fuel Systems and Three Cancer Drug Makers
(Tue, Aug 25)
More by Justin M. Hall on OSIR »
Mike Havrilla
(1926 followers)
Stem Cell Index Surges in Past Week
(Mon, May 11)
FDA, Clinical Trial Calendar Updates: Genzyme, Isis, Osiris, Roche, Watson
(Thu, Apr 23)
Banking on NeoStem
(Sun, Apr 12)
More by Mike Havrilla on OSIR »
Ketan Desai
(18 followers)
10 Biotechs in Stem Cells that Could Profit Under the Democrats
(Sun, Jun 1)
More by Ketan Desai on OSIR »